Editorial: treating hepatorenal syndrome-a window and the views. Authors' reply

Aliment Pharmacol Ther. 2020 Sep;52(5):897. doi: 10.1111/apt.15981.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Hepatorenal Syndrome* / drug therapy
  • Humans
  • Terlipressin*
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents
  • Terlipressin